Insights

Global API Leader Divi’s Laboratories is a large, revenue-generating API manufacturer exporting to over 100 countries with multiple manufacturing facilities, presenting a broad opportunity to supply customized APIs, intermediates, and nutraceutical ingredients to regulated markets in the US, Europe, and beyond.

Expansion & Capacity Recent and planned capacity expansions and greenfield/improved facilities indicate a readiness to take on higher-volume or new API projects, making this a fit for customers seeking scale, reliability, and long-term supply commitments.

Custom Synthesis Strength Strong emphasis on custom synthesis for global innovator companies suggests a capability to collaborate on development-stage or specialized API projects, offering potential for early-partner opportunities, toll manufacturing, and process optimization services.

Financial Growth Consistent revenue growth signals financial health and stability, enabling conversations around long-term contracts, price competitiveness, and willingness to invest in joint ventures or co-development arrangements.

Strategic Geography Operations and recent facility expansions in India position Divi’s as a cost-effective, geographically diversified supplier with potential to optimize supply chains for customers looking to diversify sourcing and reduce lead times in Asia-Pacific and global markets.

Similar companies to DIVIS LABORATORIES

DIVIS LABORATORIES Tech Stack

DIVIS LABORATORIES uses 8 technology products and services including Mailchimp, JSON-LD, Select2, and more. Explore DIVIS LABORATORIES's tech stack below.

  • Mailchimp
    Email
  • JSON-LD
    Javascript Frameworks
  • Select2
    Javascript Libraries
  • parallax.js
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • Google Maps
    Maps
  • Google Tag Manager
    Tag Management
  • OpenResty
    Web Servers

Media & News

DIVIS LABORATORIES's Email Address Formats

DIVIS LABORATORIES uses at least 2 format(s):
DIVIS LABORATORIES Email FormatsExamplePercentage
LFirst@divislaboratories.comDJohn@divislaboratories.com
70%
Last@divislaboratories.comDoe@divislaboratories.com
12%
FirstLast@divislaboratories.comJohnDoe@divislaboratories.com
9%
First@divislaboratories.comJohn@divislaboratories.com
9%
First@divislabs.comJohn@divislabs.com
70%
First.Last@divislabs.comJohn.Doe@divislabs.com
27%
First.MiddleLast@divislabs.comJohn.MichaelDoe@divislabs.com
3%

Frequently Asked Questions

What is DIVIS LABORATORIES's phone number?

Minus sign iconPlus sign icon
You can contact DIVIS LABORATORIES's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DIVIS LABORATORIES's official website and social media links?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's official website is divislabs.com and has social profiles on LinkedInCrunchbase.

What is DIVIS LABORATORIES's SIC code NAICS code?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does DIVIS LABORATORIES have currently?

Minus sign iconPlus sign icon
As of July 2026, DIVIS LABORATORIES has approximately 3.5K employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: K. D.Chief Executive Officer: A. S.Ceo Managing Director: D. H.. Explore DIVIS LABORATORIES's employee directory with LeadIQ.

What industry does DIVIS LABORATORIES belong to?

Minus sign iconPlus sign icon
DIVIS LABORATORIES operates in the Pharmaceutical Manufacturing industry.

What technology does DIVIS LABORATORIES use?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's tech stack includes MailchimpJSON-LDSelect2parallax.jsLodashGoogle MapsGoogle Tag ManagerOpenResty.

What is DIVIS LABORATORIES's email format?

Minus sign iconPlus sign icon
DIVIS LABORATORIES's email format typically follows the pattern of LFirst@divislaboratories.com. Find more DIVIS LABORATORIES email formats with LeadIQ.

How much funding has DIVIS LABORATORIES raised to date?

Minus sign iconPlus sign icon
As of July 2026, DIVIS LABORATORIES has raised $4.4M in funding. The last funding round occurred on Nov 07, 2022 for $4.4M.

When was DIVIS LABORATORIES founded?

Minus sign iconPlus sign icon
DIVIS LABORATORIES was founded in 1990.
DIVIS LABORATORIES logo

DIVIS LABORATORIES

Pharmaceutical ManufacturingTelangana, India1001-5000 Employees

Divi's Laboratories Limited is a pharmaceutical manufacturer that produces generic active pharmaceutical ingredients, nutraceutical ingredients, and custom synthesis of APIs and intermediates for global customers, with exports directed mainly to regulated markets in the US and Europe. Headquartered in Hyderabad, Telangana, India, the company operates multiple manufacturing facilities to support its international reach.

The company serves customers by supplying generic APIs and related ingredients and by performing tailored synthesis work to meet specific API needs. Recent developments include the start of commercial operations at its Unit III greenfield facility in Kakinada, Andhra Pradesh, underscoring ongoing capacity expansion. Divi's maintains a global presence, with operations across three manufacturing sites and a footprint in more than 100 countries.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1990
Employees
1001-5000

Section iconFunding & Financials

  • $4.4M

    DIVIS LABORATORIES has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $4.4Mas a post_ipo_equity.

  • $100M$250M

    DIVIS LABORATORIES's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $4.4M

    DIVIS LABORATORIES has raised a total of $4.4M of funding over 1 rounds. Their latest funding round was raised on Nov 07, 2022 in the amount of $4.4Mas a post_ipo_equity.

  • $100M$250M

    DIVIS LABORATORIES's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.